Provided by Tiger Trade Technology Pte. Ltd.

Merck

152.55
+3.562.39%
Pre-market: 152.650.1000+0.07%06:34 EDT
Volume:15.98M
Turnover:2.44B
Market Cap:376.37B
PE:119.85
High:154.49
Open:149.12
Low:148.59
Close:148.99
52wk High:154.49
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.07
T/O Rate:0.65%
Dividend:3.32
Dividend Rate:2.18%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.98
PE(LYR):20.95

Loading ...

Merck terminates Phase 2 Alzheimer’s study

TIPRANKS
·
Jul 02

Press Release: Merck to Hold Second-quarter 2026 Sales and Earnings Conference Call Aug. 4

Dow Jones
·
Jul 01

Merck Schedules Second-quarter 2026 Sales and Earnings Conference Call

Reuters
·
Jul 01

Sector Update: Healthcare Stocks Decline Tuesday Afternoon

MT Newswires Live
·
Jul 01

Merck's Lung Cancer Drug Seen Boosting Sales Potential, BofA Says

MT Newswires Live
·
Jun 30

Merck is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Jun 30

BofA Securities Adjusts Merck Price Target to $141 From $130, Maintains Buy Rating

MT Newswires Live
·
Jun 30

U.S. Stocks on the Move-aerovironment, Oklo

Reuters
·
Jun 30

Market Chatter: AbbVie, Merck Investigated by US House Committee Over Clinical Trials in China

MT Newswires Live
·
Jun 30

Broadcom Stock And Two AI Automation Picks Backed By Cash Flow

Simply Wall St.
·
Jun 30

Merck & Co Inc : Bofa Global Research Raises Price Objective to $141.00 from $130.00

THOMSON REUTERS
·
Jun 30

Analysts Have Conflicting Sentiments on These Healthcare Companies: Outlook Therapeutics (OTLK), Praxis Precision Medicines (PRAX) and Merck & Company (MRK)

TIPRANKS
·
Jun 30

Merck Down 1.2%, Abbvie Down 1%

THOMSON REUTERS
·
Jun 30

Exclusive-u.s. House Committee Investigates Abbvie, Merck China Drug Trials to Determine if They Fueled China's Military Capabilities

THOMSON REUTERS
·
Jun 30

Exclusive-u.s. Lawmaker Letters Request Documents on Hundreds of Trials over About 10 Years, Including on Data Protection Processes

THOMSON REUTERS
·
Jun 30

Scotiabank Raises Merck Price Target to $155 From $136, Sector Outperform Rating Kept

MT Newswires Live
·
Jun 30

Merck price target raised to $155 from $136 at Scotiabank

TIPRANKS
·
Jun 30

Merck Agrees With ADAP Crisis Task Force to Provide Access to HIV Treatment Idvynso

MT Newswires Live
·
Jun 29

Merck Says FDA Approves Once-daily HIV Combo Pill Idvynso

Reuters
·
Jun 29

Merck Announces New Agreement with Adap Crisis Task Force to Improve Access and Care for People Living with Hiv

THOMSON REUTERS
·
Jun 29